Solution: Flare

Nicola Porta, Senior Scientist, Evotec
“As a global computational chemistry team within a contract research organisation (CRO), we aimed to improve the consistency, scalability,...
Application of generative AI to design covalent inhibitors of prolyl oligopeptidase
Generative chemistry is revolutionizing drug discovery, using AI to efficiently explore entirely new areas of chemical space in the search for...
Flare™ V12 released: Significant improvements to FEP calculations and structure-based methods
We are pleased to announce the release of Flare V12, which introduces a range of new capabilities and enhancements aimed at improving the efficiency,...
Cresset releases Flare V12 to cut synthesis and testing cycles with faster, more flexible FEP
Cresset releases Flare V12, a new version of its computer-aided drug design (CADD) solution for the discovery, design and optimization of small...
Prediction before synthesis and testing: A Hit Discovery and triaging workflow for TYK2
A workflow to triage the results from a virtual screening experiment and assess binding affinity using FEP
Best practices for using the Flare™ AI Assistants
The introduction of AI assistants in Flare V11 reflects a broader objective: to streamline routine molecular modelling tasks, reduce efforts...
R-Group replacement
Find novel, biologically relevant R-Groups for your molecules
Discovery and development of EP652, A METTL3 Inhibitor with efficacy in liquid and Solid Tumour Models
We highlight computational analysis and modeling that facilitated in-silico design; providing a potent, active and tractable METTL3 inhibitor...